Is SAGE Therapeutics Inc (SAGE) Stock at the Top of the Biotechnology Industry?

The 72 rating InvestorsObserver gives to SAGE Therapeutics Inc (SAGE) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 86 percent of stocks in the Biotechnology industry, SAGE’s 72 overall rating means the stock scores better than 72 percent of all stocks.

SAGE has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on SAGE!

See Full SAGE Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With SAGE Therapeutics Inc Stock Today?

SAGE Therapeutics Inc (SAGE) stock is trading at $43.08 as of 10:52 AM on Wednesday, Mar 8, an increase of $2.33, or 5.72% from the previous closing price of $40.75. The stock has traded between $41.25 and $43.72 so far today. Volume today is below average. So far 201,390 shares have traded compared to average volume of 464,940 shares. Click Here to get the full Stock Report for SAGE Therapeutics Inc stock.